These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 23061985

  • 1. Plasmodium falciparum endoplasmic reticulum-resident calcium binding protein is a possible target of synthetic antimalarial endoperoxides, N-89 and N-251.
    Morita M, Sanai H, Hiramoto A, Sato A, Hiraoka O, Sakura T, Kaneko O, Masuyama A, Nojima M, Wataya Y, Kim HS.
    J Proteome Res; 2012 Dec 07; 11(12):5704-11. PubMed ID: 23061985
    [Abstract] [Full Text] [Related]

  • 2. Stage specific activity of synthetic antimalarial endoperoxides, N-89 and N-251, against Plasmodium falciparum.
    Morita M, Koyama T, Sanai H, Sato A, Hiramoto A, Masuyama A, Nojima M, Wataya Y, Kim HS.
    Parasitol Int; 2015 Feb 07; 64(1):113-7. PubMed ID: 25449979
    [Abstract] [Full Text] [Related]

  • 3. Genomic and biological features of Plasmodium falciparum resistance against antimalarial endoperoxide N-89.
    Morita M, Hayashi K, Sato A, Hiramoto A, Kaneko O, Isogawa R, Kurosaki Y, Miyoshi SI, Chang KS, Wataya Y, Kim HS.
    Gene; 2019 Oct 20; 716():144016. PubMed ID: 31377318
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the reactivity of antimalarial 1,2,4,5-tetraoxanes with 1,2,4-trioxolanes in the presence of ferrous iron salts, heme, and ferrous iron salts/phosphatidylcholine.
    Bousejra-El Garah F, Wong MH, Amewu RK, Muangnoicharoen S, Maggs JL, Stigliani JL, Park BK, Chadwick J, Ward SA, O'Neill PM.
    J Med Chem; 2011 Oct 13; 54(19):6443-55. PubMed ID: 21888440
    [Abstract] [Full Text] [Related]

  • 5. Novel endoperoxide antimalarials: synthesis, heme binding, and antimalarial activity.
    Taylor DK, Avery TD, Greatrex BW, Tiekink ER, Macreadie IG, Macreadie PI, Humphries AD, Kalkanidis M, Fox EN, Klonis N, Tilley L.
    J Med Chem; 2004 Mar 25; 47(7):1833-9. PubMed ID: 15027875
    [Abstract] [Full Text] [Related]

  • 6. Antimalarial activity of a synthetic endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum isolates from Gabon.
    Kreidenweiss A, Mordmüller B, Krishna S, Kremsner PG.
    Antimicrob Agents Chemother; 2006 Apr 25; 50(4):1535-7. PubMed ID: 16569877
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and antimalarial activity of dihydroperoxides and tetraoxanes conjugated with bis(benzyl)acetone derivatives.
    Franco LL, de Almeida MV, E Silva LF, Vieira PP, Pohlit AM, Valle MS.
    Chem Biol Drug Des; 2012 May 25; 79(5):790-7. PubMed ID: 22284812
    [Abstract] [Full Text] [Related]

  • 8. Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol.
    Sato A, Hiramoto A, Morita M, Matsumoto M, Komich Y, Nakase Y, Tanigawa N, Hiraoka O, Hiramoto K, Hayatsu H, Higaki K, Kawai S, Masuyama A, Nojima M, Wataya Y, Kim HS.
    Parasitol Int; 2011 Sep 25; 60(3):270-3. PubMed ID: 21501696
    [Abstract] [Full Text] [Related]

  • 9. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
    Rudrapal M, Chetia D.
    Drug Des Devel Ther; 2016 Sep 25; 10():3575-3590. PubMed ID: 27843298
    [Abstract] [Full Text] [Related]

  • 10. Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research.
    Patel OPS, Beteck RM, Legoabe LJ.
    Eur J Med Chem; 2021 Mar 05; 213():113193. PubMed ID: 33508479
    [Abstract] [Full Text] [Related]

  • 11. Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphology.
    del Pilar Crespo M, Avery TD, Hanssen E, Fox E, Robinson TV, Valente P, Taylor DK, Tilley L.
    Antimicrob Agents Chemother; 2008 Jan 05; 52(1):98-109. PubMed ID: 17938190
    [Abstract] [Full Text] [Related]

  • 12. Tetraoxanes as antimalarials: harnessing the endoperoxide.
    Fisher LC, Blackie MA.
    Mini Rev Med Chem; 2014 Feb 05; 14(2):123-35. PubMed ID: 24456270
    [Abstract] [Full Text] [Related]

  • 13. A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistry.
    Penarete-Vargas DM, Boisson A, Urbach S, Chantelauze H, Peyrottes S, Fraisse L, Vial HJ.
    PLoS One; 2014 Feb 05; 9(12):e113918. PubMed ID: 25470252
    [Abstract] [Full Text] [Related]

  • 14. Proteome analysis of new antimalarial endoperoxide against Plasmodium falciparum.
    Aly NS, Hiramoto A, Sanai H, Hiraoka O, Hiramoto K, Kataoka H, Wu JM, Masuyama A, Nojima M, Kawai S, Kim HS, Wataya Y.
    Parasitol Res; 2007 Apr 05; 100(5):1119-24. PubMed ID: 17273878
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The structure-activity relationship of the antimalarial ozonide arterolane (OZ277).
    Dong Y, Wittlin S, Sriraghavan K, Chollet J, Charman SA, Charman WN, Scheurer C, Urwyler H, Santo Tomas J, Snyder C, Creek DJ, Morizzi J, Koltun M, Matile H, Wang X, Padmanilayam M, Tang Y, Dorn A, Brun R, Vennerstrom JL.
    J Med Chem; 2010 Jan 14; 53(1):481-91. PubMed ID: 19924861
    [Abstract] [Full Text] [Related]

  • 18. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.
    Jung SY, Zheng B, Choi YY, Soh BY, Kim SY, Park KI, Park H.
    Arch Pharm Res; 2009 Jun 14; 32(6):899-906. PubMed ID: 19557368
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277).
    Uhlemann AC, Wittlin S, Matile H, Bustamante LY, Krishna S.
    Antimicrob Agents Chemother; 2007 Feb 14; 51(2):667-72. PubMed ID: 17145800
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.